Aquestive Therapeutics Stock (NASDAQ: AQST) stock price, news, charts, stock research, profile.
Open | $4.270 |
Close | $4.260 |
Volume / Avg. | 7.208M / 1.947M |
Day Range | 4.220 - 4.480 |
52 Wk Range | 0.820 - 6.230 |
Market Cap | $388.661M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | 3.09% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aquestive Therapeutics (NASDAQ: AQST) through any online brokerage.
Other companies in Aquestive Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Third Harmonic Bio (NASDAQ:THRD), Zevra Therapeutics (NASDAQ:ZVRA) and GH Research (NASDAQ:GHRS).
The latest price target for Aquestive Therapeutics (NASDAQ: AQST) was reported by Raymond James on Thursday, March 28, 2024. The analyst firm set a price target for 7.00 expecting AQST to rise to within 12 months (a possible 62.04% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $4.32 last updated March 28, 2024 at 7:51 PM EDT.
There are no upcoming dividends for Aquestive Therapeutics.
Aquestive Therapeutics’s Q4 earnings are confirmed for Tuesday, March 7, 2023.
There is no upcoming split for Aquestive Therapeutics.
Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.